肝炎和可持续发展目标:结束时间

Here, Jeffrey Lazarus talks about the need for a global goal of eliminating viral hepatitis.

3

这个博客已经重新播放西班牙语on the IS Global website.

Well it’s official. The governments of the world have committed to ending HIV, tuberculosis and malaria, but merely ‘combatting’ viral hepatitis.

When the United Nations General Assembly voted to adopt the可持续发展目标(可持续发展目标)9月25日,我毫不怀疑许多条纹的拥护者感到这种高度影响力的协议没有充分意识到其主张的紧迫性。

It is not my intention to argue that viral hepatitis advocates have been short-changed any more than those who care deeply about other issues. I do, however, think it is important for everyone committed to ending viral hepatitis to think about what this aspect of the SDGs means to us.

Goal 3.3 reads:到2030年,结束了艾滋病,结核病,疟疾以及被忽视的热带疾病以及战斗肝炎,水传播疾病和其他传染病的流行。

It is estimated that combined mortality from hepatitis B virus (HBV) and hepatitis C virus (HCV) exceeded HIV-related mortality in 2013.

据估计,来自乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)的共同死亡率在2013年超过与HIV相关的死亡率。与HIV不同,HBV可以通过疫苗来预防HIV。与艾滋病毒不同的HCV是可治愈的。渴望结束艾滋病毒而不是HBV和HCV可能有意义?

The question is irrelevant, because the complex years-long consultation and negotiation processes that gave rise to the SDGs were not about applying this lens. While the SDGs are intended to present a unified and holistic development vision, efforts to acknowledge the priorities of a vast array of interest groups have resulted in a final document that might be metaphorically described as an extremely large patchwork quilt assembled under duress.

在这种情况下,与其批评联合国的成员国未能认识到病毒性肝炎所构成的威胁的巨大威胁,也许我们应该将其视为进步的迹象,表明病毒性肝炎 - 在千年发展中根本没有提及目标 - 现在存在。毕竟,尽管近年来新的流行病学证据极大地帮助了我们的倡导努力,但它花费的时间比我们任何人都希望向政策制定者和普通公众提供有关肝炎的巨大负担的时间更长。

I am quite certain that the growing momentum in our field will catapult viral hepatitis into the mainstream public consciousness within the next two to three years.

I am quite certain that the growing momentum in our field will catapult viral hepatitis into the mainstream public consciousness within the next two to three years. When that has happened, and驱逐淘汰已成为全球健康局势的公认元素,在SDG 3.3中使用动词“战斗”将标志着病毒肝炎的目标本质上已经过时。

But in the meantime, we have urgent business – urgent because indicators for measuring progress on the SDGs will most likely be determined between now and March 2016. We have the opportunity to speed along the process of making efforts to ‘combat’ hepatitis seem outdated by insisting on explicitly面向消除的指标for HBV and HCV.

A联合国统计委员会子组is in the process of developing draft SDG indicators to submit to the General Assembly, and it will next convene in Bangkok in late October. The clock is ticking. How can we work together to secure SDG indicators that will embody the reality that the elimination of viral hepatitis is within reach?


Hepatology, Medicine and Policyis now accepting submissions on this and related issues. For more information, visit:www.hmap.biomedcentral.com.

View the latest posts on the On Health homepage

3注释

Dr. Humayun Kabir

Thank you very much Professor Jeffrey for your pragmatic idea on the crucial issue of elimination of viral hepatitis and the considerations of SDG policy makers taking the issue so lightly. I think nobody was there to raise such a vital and technical issue in time. You have rightly pointed out the easiest way of recovery which we already lost. We must have to find valid indicators that can bring a effective change towards the goal of our alliance. Let us start thinking the phase-wise target and indicators where governments come forward to share it through fulfilling their commitment and national policies.

期待进一步的想法或您身边的任何发展。

杰夫·拉撒路(Jeff Lazarus)

Thank you very much for the thoughtful comment. As noted in the blog post, there is still a window of opportunity to input into the target-setting process. I know the World Hepatitis Alliance and several others are looking into this, but any suggestions anyone has on how exactly to do this are very welcome. More specifically, we need to reach out to hepatitis champion countries to raise the issue at the highest level possible.

Dr. Humayun Kabir

Of course it is a very hard task to achieve the goal like “elimination” of viral hepatitis because of its complex nature of chronicity. But if we want to achieve something substantially whatever the name is, phase wise feasible targets must have to think first. And accordingly suitable indicators may be put forward. Thanks.

注释are closed.